Dementia: Diagnosis, Treatment, and Comprehensive Care Guide

Dementia is a syndrome, not a specific disease, characterized by a decline in cognitive function severe enough to interfere with daily life. It encompasses a group of symptoms affecting memory, thinking, and social abilities. Understanding the diagnosis, treatment, and care options is crucial for individuals and families facing this challenging condition.

Diagnosing Dementia: Identifying the Cause and Extent of Cognitive Decline

Diagnosing dementia involves a comprehensive approach to pinpoint the underlying cause of cognitive decline and assess the individual’s functional abilities. Healthcare professionals focus on recognizing patterns of skill and functional loss, evaluating remaining capabilities, and increasingly utilizing biomarkers for more precise diagnoses, especially in Alzheimer’s disease.

The diagnostic process typically begins with a thorough review of medical history, symptom evaluation, and a physical examination. Input from close family members or caregivers is also valuable in understanding the individual’s symptoms and functional changes. It’s important to note that there’s no single test to definitively diagnose dementia; instead, a combination of assessments is necessary to identify the problem accurately.

Cognitive and Neuropsychological Assessments

These tests are fundamental in evaluating thinking abilities. They encompass a range of evaluations designed to measure various cognitive skills, including:

• Memory: Assessing short-term and long-term recall.
• Orientation: Determining awareness of time, place, and person.
• Reasoning and Judgment: Evaluating problem-solving and decision-making skills.
• Language Skills: Assessing verbal fluency, comprehension, and naming abilities.
• Attention: Measuring focus and concentration.

These tests help quantify the extent of cognitive impairment and identify specific areas of cognitive weakness, providing valuable insights into the nature of the dementia.

Neurological Examination

A neurological evaluation is crucial to assess physical and neurological functions that may be affected by dementia or contribute to cognitive decline. This examination includes:

• Memory and Language Skills Assessment: Further evaluation beyond cognitive tests.
• Visual Perception: Testing the ability to interpret visual information.
• Attention and Problem-Solving Skills: Neurological aspects of these cognitive functions.
• Motor Skills: Assessing movement, coordination, and gait.
• Senses and Balance: Checking for sensory and balance impairments.
• Reflexes: Evaluating neurological reflexes.

This comprehensive neurological assessment helps rule out other neurological conditions and identify physical impairments that might impact cognitive function or daily activities.

Brain Imaging Scans

Brain scans are essential tools in dementia diagnosis, providing visual information about brain structure and function. Common types of brain scans used include:

• CT (Computed Tomography) or MRI (Magnetic Resonance Imaging): These scans help detect structural abnormalities in the brain, such as:

  • Stroke: Evidence of past or recent strokes.
  • Bleeding: Intracranial hemorrhage.
  • Tumors: Abnormal growths in the brain.
  • Hydrocephalus: Fluid buildup in the brain.

• PET (Positron Emission Tomography) Scans: PET scans offer insights into brain activity and metabolic function. They can:

  • Show patterns of brain activity: Identifying areas of reduced or abnormal activity.
  • Detect amyloid or tau protein deposits: These are hallmark proteins associated with Alzheimer’s disease and can be visualized in PET scans using specific tracers.

Brain scans are vital for differentiating between various types of dementia and ruling out other conditions that may mimic dementia symptoms.

Laboratory Tests

Laboratory tests, particularly blood tests, are crucial to identify underlying systemic conditions that can impact brain function and cause dementia-like symptoms. These tests may include:

• Vitamin B-12 levels: Deficiency can cause cognitive impairment.
• Thyroid function tests: Hypothyroidism (underactive thyroid) can affect brain function.
• Spinal fluid analysis (in some cases): Examining cerebrospinal fluid can help detect:
  • Infections: Such as meningitis or encephalitis.
  • Inflammation: Indicating inflammatory conditions affecting the brain.
  • Markers of degenerative diseases: Specific proteins or substances associated with certain types of dementia.

Laboratory tests help identify treatable conditions that may be contributing to cognitive decline, some of which are reversible if addressed promptly.

Psychiatric Evaluation

A psychiatric evaluation is important to differentiate dementia from mental health conditions that can present with similar symptoms, such as depression. A mental health professional can assess:

• Mood disorders: Depression, anxiety, and other mood-related conditions.
• Other psychiatric conditions: To rule out or identify co-existing mental health issues that might be contributing to cognitive symptoms.

Distinguishing between dementia and psychiatric conditions is essential for accurate diagnosis and appropriate treatment planning.

Dementia Treatment: Managing Symptoms and Slowing Progression

While most types of dementia currently have no cure, various treatment strategies are available to manage symptoms, improve quality of life, and in some cases, slow the progression of the disease. Treatment approaches include medications and non-pharmacological therapies.

Medications for Cognitive Symptoms

Several medications are approved to temporarily alleviate cognitive symptoms in certain types of dementia, particularly Alzheimer’s disease. These medications primarily focus on enhancing neurotransmitter activity in the brain.

• Cholinesterase Inhibitors: These drugs increase the levels of acetylcholine, a neurotransmitter crucial for memory and judgment. Commonly prescribed cholinesterase inhibitors include:

  • Donepezil (Aricept, Adlarity)
  • Rivastigmine (Exelon)
  • Galantamine (Razadyne ER)

  While primarily used for Alzheimer’s disease, these medications may also be beneficial for other dementias like vascular dementia, Parkinson’s disease dementia, and Lewy body dementia. Common side effects can include nausea, vomiting, diarrhea, slowed heart rate, fainting, and sleep disturbances.

• Memantine (Namenda): Memantine regulates the activity of glutamate, another neurotransmitter involved in learning and memory. It is sometimes used in combination with cholinesterase inhibitors, especially in moderate to severe Alzheimer’s disease. Dizziness is a common side effect.

• Newer Alzheimer’s Disease Medications: The FDA has recently approved lecanemab (Leqembi) and donanemab (Kisunla) for individuals with mild Alzheimer’s disease and mild cognitive impairment due to Alzheimer’s. These medications are disease-modifying therapies that target amyloid plaques, a hallmark of Alzheimer’s disease.

  • Lecanemab (Leqembi): Administered as an intravenous (IV) infusion every two weeks, lecanemab has shown to slow cognitive and functional decline in early Alzheimer’s. Side effects can include infusion-related reactions (fever, flu-like symptoms, nausea), dizziness, and potential brain swelling or bleeding (amyloid-related imaging abnormalities – ARIA).

  • Donanemab (Kisunla): Given as an IV infusion every four weeks, donanemab also targets amyloid plaques and has demonstrated similar benefits in slowing Alzheimer’s progression. Side effects are comparable to lecanemab, including infusion reactions and ARIA. Genetic testing for APOE e4 gene is recommended before starting these treatments due to an increased risk of ARIA in carriers. Regular MRI monitoring is also necessary during treatment.

• Medications for Co-existing Conditions and Symptoms: Individuals with dementia may also require medications to manage related conditions or symptoms, such as:

  • Depression
  • Sleep problems
  • Hallucinations
  • Agitation
  • Parkinsonism

Non-Pharmacological Therapies

Non-drug therapies play a vital role in managing dementia symptoms and enhancing quality of life. These therapies often address behavioral and functional challenges and can be used alongside or in place of medications, especially initially.

• Occupational Therapy: Occupational therapists help individuals and caregivers adapt to the challenges of dementia by:

  • Home safety modifications: Recommending changes to reduce fall risks and improve safety.
  • Coping strategies: Teaching techniques to manage daily tasks and challenging behaviors.
  • Preparing for disease progression: Planning for future needs and adapting strategies as dementia advances.

• Environmental Modifications: Creating a supportive and structured environment is crucial. This includes:

  • Reducing clutter and noise: To minimize distractions and improve focus.
  • Safety measures: Hiding potentially dangerous objects like knives or car keys.
  • Monitoring systems: Using technology to alert caregivers if the person wanders.

• Task Simplification: Breaking down complex tasks into smaller, manageable steps can promote independence and reduce frustration. Focusing on successes rather than failures is essential. Establishing routines and structure provides predictability and reduces confusion.

• Other Therapies: Several other therapies can be beneficial in managing specific symptoms and promoting well-being:

  • Music Therapy: Listening to calming music can reduce agitation and promote relaxation.
  • Light Exercise: Regular physical activity can improve mood, reduce restlessness, and enhance physical health.
  • Pet Therapy: Interaction with animals can improve mood and behavior.
  • Aromatherapy: Using essential oils for relaxation and mood enhancement.
  • Massage Therapy: Promoting relaxation and reducing muscle tension.
  • Art Therapy: Engaging in creative activities can provide emotional expression and reduce agitation.

Lifestyle Adjustments and Home Care Strategies

Lifestyle modifications and home remedies are integral to dementia care, focusing on maximizing independence, safety, and quality of life for individuals and their caregivers.

• Enhancing Communication: Effective communication is key. Strategies include:

  • Maintaining eye contact: To ensure focus and engagement.
  • Speaking slowly and clearly: Using simple sentences and avoiding complex language.
  • Presenting one idea at a time: To avoid overwhelming the person.
  • Using gestures and cues: Visual aids to support understanding.

• Encouraging Physical Exercise: Regular exercise offers numerous benefits:

  • Improved physical health: Strength, balance, cardiovascular health.
  • Symptom management: Reduced restlessness, improved mood.
  • Potential brain protection: Emerging evidence suggests exercise may slow dementia progression, especially when combined with a healthy diet and management of cardiovascular risk factors.

• Engaging in Meaningful Activities: Planning enjoyable and doable activities can enhance well-being and connection:

  • Dancing, painting, gardening, cooking, singing: Activities that align with the person’s interests and abilities.
  • Focusing on retained abilities: Emphasizing what the person can still do to maintain self-esteem and purpose.

• Establishing a Nighttime Routine: Sundowning (increased confusion and agitation in the evening) is common. Strategies include:

  • Calming bedtime routine: Quiet activities away from stimulating environments.
  • Night lights: To prevent disorientation and falls.
  • Limiting caffeine and daytime naps: To improve nighttime sleep.
  • Daytime exercise: To promote physical activity and tire the person for sleep.

• Using Calendars and Reminders: Calendars can help with orientation and memory:

  • Tracking events, activities, and medication schedules: Visual aids to improve memory.
  • Shared calendars: Involving the person in managing their schedule.

• Planning for the Future: Early planning is essential while the person can still participate in decision-making:

  • Advance care planning: Documenting wishes for future care.
  • Legal and financial planning: Addressing legal and financial matters.
  • Safety and daily living considerations: Planning for increasing care needs.
  • Long-term care options: Exploring potential long-term care arrangements.

Coping and Support for Individuals and Caregivers

Dementia impacts not only the individual diagnosed but also their families and caregivers. Access to support and coping strategies is crucial for navigating the challenges of dementia.

Support for Individuals with Dementia

• Education: Learn about dementia, memory loss, and Alzheimer’s disease to understand the condition and its progression.
• Journaling: Express feelings and thoughts through writing.
• Support Groups: Connect with others facing similar experiences for emotional support and practical advice.
• Counseling: Individual or family counseling can provide emotional support and coping strategies.
• Spiritual Support: Engage with spiritual communities or advisors for comfort and guidance.
• Staying Active and Involved: Maintain social connections, hobbies, and activities to promote well-being.
• Online Communities: Connect with online support groups for peer support and information.
• Creative Expression: Explore new ways to express oneself through art, music, or writing.
• Delegating Decision-Making: Identify a trusted person to assist with decision-making as needed.

Support for Caregivers and Care Partners

Caregiving for someone with dementia is demanding physically and emotionally. Caregivers need support to prevent burnout and maintain their well-being.

• Education: Participate in caregiver education programs to learn about dementia and caregiving strategies.
• Respite Care: Utilize respite care services for temporary breaks from caregiving responsibilities.
• Adult Day Care: Explore adult day care programs for structured activities and social interaction for the person with dementia, providing caregivers with daytime relief.
• Seeking Help from Friends and Family: Enlist support from social networks for practical and emotional assistance.
• Prioritizing Self-Care: Maintain physical, emotional, and spiritual health through healthy habits and stress management techniques.
• Seeking Professional Guidance: Consult healthcare professionals, social workers, and dementia specialists for advice and support.
• Joining Caregiver Support Groups: Connect with other caregivers for peer support, shared experiences, and practical tips.

Preparing for a Healthcare Appointment

Seeking timely medical evaluation is crucial if you or a loved one experiences symptoms of dementia. Preparation for the appointment can ensure effective communication and optimal outcomes.

What to Do Before the Appointment

• Inquire about pre-appointment preparations: Ask if fasting or other specific preparations are needed for tests.
• Symptom List: Document all symptoms, including seemingly unrelated ones, and their onset.
• Key Personal Information: Note major life stresses, recent changes, and family medical history.
• Medication List: Compile a list of all medications, vitamins, and supplements, including dosages.
• Questions to Ask: Prepare a list of questions for the healthcare professional.

Bringing a family member, friend, or caregiver to the appointment is highly recommended, especially in the early stages of dementia, to aid in information retention and communication.

Questions to Ask Your Doctor

• What is the likely cause of my symptoms?
• Are there other possible causes?
• What tests are needed?
• Is the condition temporary or chronic?
• What is the best course of action?
• Are there alternative approaches?
• How can dementia and other health issues be managed together?
• Are there brochures or recommended websites for information?

Don’t hesitate to ask any other questions or express concerns.

What to Expect from Your Doctor

Your doctor will likely ask questions to understand your symptoms and medical history, such as:

• When did symptoms begin?
• Are symptoms constant or occasional?
• How severe are the symptoms?
• What improves or worsens symptoms?
• How do symptoms affect daily life?

By understanding the diagnosis, treatment, and care aspects of dementia, individuals and families can better navigate this complex condition and strive for the best possible quality of life.

Request an appointment

Symptoms & causes
Doctors & departments

References

1. What is dementia? Alzheimer’s Association. https://www.alz.org/alzheimers-dementia/what-is-dementia. Accessed April 24, 2023.
2. Dementias. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Hope-Through-Research/Dementia-Hope-Through-Research. Accessed April 24, 2023.
3. Larson EB. Evaluation of cognitive impairment and dementia. https://www.uptodate.com/contents/search. Accessed April 24, 2023.
4. Rao RV, et al. Rationale for multi-factorial approach for the reversal of cognitive decline in Alzheimer’s disease and MCI: A review. International Journal of Molecular Sciences. 2023; doi:10.3390/ijms24021659.
5. Press D, et al. Management of the patient with dementia. https://www.uptodate.com/contents/search. Accessed April 24, 2023.
6. Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020; doi:10.1016/S0140-6736(20)30367-6.
7. Luo G, et al. Effectiveness of non-pharmacological therapies on cognitive function in patients with dementia — A network meta-analysis of randomized controlled trials. Frontiers in Aging: Neuroscience. 2023; doi:10.3389/fnagi.2023.1131744.
8. Creutzfeldt-Jakob disease, classic (CJD): Occurrence and transmission. Centers for Disease Control and Prevention. https://www.cdc.gov/prions/cjd/occurrence-transmission.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fprions%2Fcjd%2Foccurance-transmisison.html. Accessed April 24, 2023.
9. Palimariciuc M, et al. The quest for neurodegenerative disease treatment — Focusing on Alzheimer’s disease personalised diets. Current Issues in Molecular Biology. 2023; doi:10.3390/cimb45020098.
10. Dementia. Merck Manual Professional Version. https://www.merckmanuals.com/professional/neurologic-disorders/delirium-and-dementia/dementia. Accessed April 24, 2023.
11. Press D, et al. Prevention of dementia. https://www.uptodate.com/contents/search. Accessed April 24, 2023.
12. Sleep issues and sundowning. Alzheimer’s Association. https://www.alz.org/help-support/caregiving/stages-behaviors/sleep-issues-sundowning. Accessed May 2, 2023.
13. Medications for memory. Alzheimer’s Association. https://www.alz.org/alzheimers-dementia/treatments/medications-for-memory. Accessed April 24, 2023.
14. How to communicate with a person with dementia. Alzheimer’s Society. https://www.alzheimers.org.uk/about-dementia/symptoms-and-diagnosis/symptoms/tips-for-communicating-dementia. Accessed April 24, 2023.
15. Press D, et al. Management of neuropsychiatric symptoms of dementia. https://www.uptodate.com/search/contents. Accessed May 2, 2023.
16. Leqembi (approval letter). Biologic License Application 761269. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761269. Accessed July 7, 2023.
17. Lecanemab approved for treatment of early Alzheimer’s disease. Alzheimer’s Association. https://www.alz.org/alzheimers-dementia/treatments/lecanemab-leqembi. Accessed May 4, 2023.
18. Van Dyck CH, et al. Lecanemab in early Alzheimer’s disease. New England Journal of Medicine. 2023; doi:10.1056/NEJMoa2212948.
19. Shi M, et al. Impact of anti-amyloid-β monoclonal antibodies on the pathology and clinical profile of Alzheimer’s disease: A focus on aducanumab and lecanemab. Frontiers in Aging and Neuroscience. 2022; doi:10.3389/fnagi.2022.870517.
20. Cummings J, et al. Alzheimer’s disease drug development pipeline: 2022. Alzheimer’s and Dementia. 2022; doi:10.1002/trc2.12295.
21. Oxybutynin oral. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed April 28, 2023.
22. Diphenhydramine oral. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed April 28, 2023.
23. Rashad A, et al. Donanemab for Alzheimer’s disease: A systematic review of clinical trials. Healthcare. 2022; doi:10.3390/healthcare11010032.
24. Budson AE, et al. Cholinesterase inhibitors. In: Memory Loss, Alzheimer’s Disease, and Dementia. 3rd ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed May 4, 2023.
25. Leqembi (prescribing information). Eisai; 2023. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=761269. Accessed July 10, 2023.
26. Mintun MA, et al. Donanemab in early Alzheimer’s disease. New England Journal of Medicine. 2021; doi:10.1056/NEJMoa2100708.
27. Graff-Radford J (expert opinion). Mayo Clinic. May 15, 2023.
28. Ami TR. Allscripts EPSi. Mayo Clinic. May 17, 2023.
29. Kisunla (approval letter). Biologic License Application 761248. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process. Accessed July 9, 2024.
30. Sims JR, et al. Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023; doi:10.1001/jama.2023.13239.
31. Kisunla (prescribing information). Eli Lilly and Company; 2024. https://www.lilly.com/. Accessed July 3, 2024.
32. Livingston G, et al. Dementia prevention, intervention and care: 2024 report of the Lancet standing Commission. Lancet. 2024; doi:10.1016/S0140-6736(24)01296-0.